BOM:509079 (India)
Â
Shs Dematerialised
₹
387.95
-8.2 (-2.07%)
Jul 16
Business Description
Gufic Biosciences Ltd
ISIN : INE742B01025
Share Class Description:
BOM:509079: Shs DematerialisedTotal Employee Number:
2,926Compare
Compare
Traded in other countries / regions
509079.India IPO Date
2000-09-25Description
Gufic Biosciences Ltd is engaged in the manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals, and related services. Geographically, it derives a majority of revenue from India. Its product portfolio includes Criticare, Criticare Life, Ferticare, Spark, Herbal, and other products. The company's lyophilized product includes antibiotics, anti-fungal, cardiac, infertility, anti-viral, and a proton-pump inhibitor. It derives maximum revenue from India.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.19 | |||||
Equity-to-Asset | 0.5 | |||||
Debt-to-Equity | 0.61 | |||||
Debt-to-EBITDA | 2.63 | |||||
Interest Coverage | 3.29 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 4.74 | |||||
Beneish M-Score | -2.15 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.3 | |||||
3-Year EBITDA Growth Rate | 3.1 | |||||
3-Year EPS without NRI Growth Rate | -8 | |||||
3-Year Book Growth Rate | 22.7 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 45.32 | |||||
9-Day RSI | 52.95 | |||||
14-Day RSI | 55.97 | |||||
3-1 Month Momentum % | 22.27 | |||||
6-1 Month Momentum % | 17.57 | |||||
12-1 Month Momentum % | -2.81 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.55 | |||||
Quick Ratio | 0.92 | |||||
Cash Ratio | 0.15 | |||||
Days Inventory | 222.72 | |||||
Days Sales Outstanding | 120.63 | |||||
Days Payable | 160.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.03 | |||||
Dividend Payout Ratio | 0.02 | |||||
Forward Dividend Yield % | 0.03 | |||||
5-Year Yield-on-Cost % | 0.05 | |||||
3-Year Average Share Buyback Ratio | -1.1 | |||||
Shareholder Yield % | -1.78 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 55.38 | |||||
Operating Margin % | 12.77 | |||||
Net Margin % | 6.8 | |||||
EBITDA Margin % | 16.31 | |||||
FCF Margin % | 1.46 | |||||
OCF Margin % | 4.76 | |||||
ROE % | 10.15 | |||||
ROA % | 5.09 | |||||
ROIC % | 8.9 | |||||
3-Year ROIIC % | 0.86 | |||||
ROC (Joel Greenblatt) % | 12.97 | |||||
ROCE % | 15.35 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 60.62 | |||||
PE Ratio without NRI | 60.62 | |||||
Shiller PE Ratio | 61.34 | |||||
PEG Ratio | 8.19 | |||||
PS Ratio | 4.11 | |||||
PB Ratio | 5.85 | |||||
Price-to-Tangible-Book | 5.91 | |||||
Price-to-Free-Cash-Flow | 282.34 | |||||
Price-to-Operating-Cash-Flow | 86.56 | |||||
EV-to-EBIT | 34.25 | |||||
EV-to-EBITDA | 27.41 | |||||
EV-to-Revenue | 4.46 | |||||
EV-to-FCF | 308.86 | |||||
Price-to-GF-Value | 0.95 | |||||
Price-to-Projected-FCF | 23.53 | |||||
Price-to-DCF (Earnings Based) | 2.54 | |||||
Price-to-DCF (FCF Based) | 30.4 | |||||
Price-to-Median-PS-Value | 1.4 | |||||
Price-to-Graham-Number | 3.99 | |||||
| Price-to-Net-Current-Asset-Value | 31.21 | |||||
Earnings Yield (Greenblatt) % | 2.92 | |||||
FCF Yield % | 0.35 | |||||
Forward Rate of Return (Yacktman) % | 6.56 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gufic Biosciences Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 9,440.066 | ||
| EPS (TTM) (₹) | 6.4 | ||
| Beta | 0.5115 | ||
| 3-Year Sharpe Ratio | 0.48 | ||
| 3-Year Sortino Ratio | 0.82 | ||
| Volatility % | 36.96 | ||
| 14-Day RSI | 55.97 | ||
| 14-Day ATR (₹) | 17.110279 | ||
| 20-Day SMA (₹) | 381.6975 | ||
| 12-1 Month Momentum % | -2.81 | ||
| 52-Week Range (₹) | 267.5 - 447.85 | ||
| Shares Outstanding (Mil) | 100.28 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gufic Biosciences Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gufic Biosciences Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| Second quarter earnings conference call for 2027 | 2026-11-17 16:30 | In 124 days | ||
| Second quarter earnings results for 2027 | 2026-11-17 | In 123 days | ||
| General meeting for 2026 | 2026-09-29 15:30 | In 75 days | ||
| Annual report for 2026 | 2026-09-04 | In 49 days | ||
| First quarter earnings conference call for 2027 | 2026-08-14 12:00 | In 29 days | ||
| First quarter earnings results for 2027 | 2026-08-14 | In 28 days | ||
| Fourth quarter earnings conference call for 2026 | 2026-06-01 16:30 | 334.90 (+0.80%) | ||
| Fourth quarter earnings results for 2026 | 2026-06-01 | 334.90 (+0.80%) | ||
| Third quarter earnings conference call for 2026 | 2026-02-16 16:30 | 307.65 (+1.43%) | ||
| Third quarter earnings results for 2026 | 2026-02-16 | 307.65 (+1.43%) |
Show
Entries
Gufic Biosciences Ltd Frequently Asked Questions
What is Gufic Biosciences Ltd(BOM:509079)'s stock price today?
The current price of BOM:509079 is ₹387.95. The 52 week high of BOM:509079 is ₹447.85 and 52 week low is ₹267.50.
When is next earnings date of Gufic Biosciences Ltd(BOM:509079)?
The next earnings date of Gufic Biosciences Ltd(BOM:509079) is 2026-08-14 Est..
Does Gufic Biosciences Ltd(BOM:509079) pay dividends? If so, how much?
The Dividend Yield %  of Gufic Biosciences Ltd(BOM:509079) is 0.03% (As of Today), Highest Dividend Payout Ratio of Gufic Biosciences Ltd(BOM:509079) was 0.04. The lowest was 0.01. And the median was 0.02. The  Forward Dividend Yield % of Gufic Biosciences Ltd(BOM:509079) is 0.03%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Gufic Biosciences Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers